SEC 13F Intelligence

Rovida Advisors Inc. / TAK

Rovida Advisors Inc.’s Takeda Pharmaceutical Co Ltd Position

Does Rovida Advisors Inc. own Takeda Pharmaceutical Co Ltd (TAK)? Not currently — the last reported position was 1.16M shares worth $23M in Q4 2019; the fund’s latest 13F (Q4 2025) no longer reports it.

Position Value
$23M
Q4 2019
Shares
1.16M
% of Portfolio
+1.21%
Quarters Held
1
position exited

Position History TAK

Reported value by quarter
Q4 ’19: $23MQ4 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20191.16M$23M+1.21%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rovida Advisors Inc.’s full portfolio or all institutional holders of TAK.